Katherine K. Matthay
Impact in
- Neurology top 0.01%
- Neuroblastoma Research and Treatments
- Neurofibromatosis and Schwannoma Cases
- Cancer Research top 0.05%
- Cancer, Hypoxia, and Metabolism
Papers in
- Neurology 211
- Neuroblastoma Research and Treatments 205
-
- Cancer, Hypoxia, and Metabolism 51
- Co-authors
- Robert C. Seeger (54 shared papers)John M. Maris (48 shared papers)Wendy B. London (49 shared papers)Hiroyuki Shimada (46 shared papers)Daniel O. Stram (34 shared papers)Susan L. Cohn (39 shared papers)Robert B. Gerbing (31 shared papers)C. Patrick Reynolds (29 shared papers)
- Journals
- Journal of Clinical Oncology (65 papers)Pediatric Blood & Cancer (43 papers)Cancer (20 papers)International Journal of Radiation Oncology*Biology*Physics (12 papers)European Journal of Cancer (9 papers)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Katherine K. Matthay
298 papers receiving 26.4k citations
Katherine K. Matthay's Hit Papers
Peers
Comparison fields: 5 of 152
- Neurology 18.0k
- Cancer Research 5.5k
- Genetics 1.5k
- Oncology 3.6k
- Molecular Biology 8.3k
Countries citing papers authored by Katherine K. Matthay
This map shows the geographic impact of Katherine K. Matthay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine K. Matthay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine K. Matthay more than expected).
Fields of papers citing papers by Katherine K. Matthay
This network shows the impact of papers produced by Katherine K. Matthay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine K. Matthay. The network helps show where Katherine K. Matthay may publish in the future.
Co-authors
The 25 scholars most cited alongside Katherine K. Matthay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 302 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid Hit paper breakdown → | 1999 | 1437 |
| 2 | Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Hit paper breakdown → | 1991 | 1334 |
| 3 | The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report Hit paper breakdown → | 2008 | 1284 |
| 4 | Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma Hit paper breakdown → | 2010 | 1262 |
| 5 | Neuroblastoma Hit paper breakdown → | 2016 | 930 |
| 6 | The International Neuroblastoma Pathology Classification (the Shimada system) Hit paper breakdown → | 1999 | 742 |
| 7 | The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report Hit paper breakdown → | 2008 | 694 |
| 8 | Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study Hit paper breakdown → | 2009 | 630 |
| 9 | Advances in Risk Classification and Treatment Strategies for Neuroblastoma Hit paper breakdown → | 2015 | 621 |
| 10 | 1999 | 495 | |
| 11 | 2005 | 406 | |
| 12 | 2005 | 399 | |
| 13 | 1999 | 316 | |
| 14 | 2011 | 301 | |
| 15 | 2003 | 264 | |
| 16 | 2011 | 233 | |
| 17 | Advancing therapy for neuroblastoma Hit paper breakdown → | 2022 | 224 |
| 18 | 2017 | 223 | |
| 19 | 2012 | 216 | |
| 20 | 2013 | 215 |
About Katherine K. Matthay
Katherine K. Matthay is a scholar working on Neurology, Cancer Research, Molecular Biology, Surgery and Pulmonary and Respiratory Medicine, having authored 302 papers that have together received 26.8k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (205 papers), Cancer, Hypoxia, and Metabolism (51 papers), Adrenal and Paraganglionic Tumors (27 papers), Cancer therapeutics and mechanisms (21 papers), Sarcoma Diagnosis and Treatment (19 papers), Childhood Cancer Survivors' Quality of Life (14 papers), Neuroendocrine Tumor Research Advances (9 papers) and Glioma Diagnosis and Treatment (9 papers). The work is most often cited by research in Neurology (18.0k citations), Cancer Research (5.5k citations), Genetics (1.5k citations), Oncology (3.6k citations) and Molecular Biology (8.3k citations). Katherine K. Matthay has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Robert C. Seeger, John M. Maris, Wendy B. London, Hiroyuki Shimada, Daniel O. Stram, Susan L. Cohn, Robert B. Gerbing, C. Patrick Reynolds, Judith G. Villablanca and Garrett M. Brodeur. Their work appears in journals such as Journal of Clinical Oncology, Pediatric Blood & Cancer, Cancer, International Journal of Radiation Oncology*Biology*Physics and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.